OpenBilldrug price receipt

NADAC week of 2026-10-14

ATENOLOL 50 MG TABLET

For 30 tablets

Pharmacies pay

$0.71 filed

30 × $0.0236 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$2.64 filed

30 × $0.08799 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

3.7× estimated

Medicare paid 3.7× what pharmacies pay.

Part D averages every strength and form sold under “Atenolol” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-09-30 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$5.82 estimated

$0.71 + $0.11 (15%) + $5.00 fee per fill = $5.82

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-09-30 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

ATENOLOL 50 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as atenolol.

FDA gives its dosage form as tablet and its route as oral.

FDA lists 8 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc. and Unichem Pharmaceuticals (USA), Inc.

FDA’s Established Pharmacologic Class for it is beta-Adrenergic Blocker.

The NADAC file of 2026-10-14 prices it under 17 NDCs (National Drug Codes); the FDA directory lists 15 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $0.71 for 30 tablets (30 × $0.0236 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-09-23 and 2026-09-30. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 8 labelers

LabelerNDCsPharmacies pay per unit
Unichem Pharmaceuticals (USA), Inc.3$0.0236 per EA filed
Aurobindo Pharma Limited2$0.0236 per EA filed
Mylan Pharmaceuticals Inc.2$0.0236 per EA filed
Rising Pharma Holdings, Inc.2$0.0236 per EA filed
Teva Pharmaceuticals USA, Inc.2$0.0236 per EA filed
Zydus Pharmaceuticals USA Inc.2$0.0236 per EA filed
Ipca Laboratories Limited1$0.0236 per EA filed
Mylan Institutional Inc.1$0.0236 per EA filed
Not listed as a package in the FDA directory2$0.0236 per EA filed

When these prices took effect

All 17 NDCs, with labeler and price
  • 00093-0752-01 · Teva Pharmaceuticals USA, Inc. · $0.0236 per EA · eff. 2026-09-23 filed
  • 00093-0752-10 · Teva Pharmaceuticals USA, Inc. · $0.0236 per EA · eff. 2026-09-23 filed
  • 00378-0231-01 · Mylan Pharmaceuticals Inc. · $0.0236 per EA · eff. 2026-09-23 filed
  • 00378-0231-10 · Mylan Pharmaceuticals Inc. · $0.0236 per EA · eff. 2026-09-23 filed
  • 29300-0411-01 · Unichem Pharmaceuticals (USA), Inc. · $0.0236 per EA · eff. 2026-09-23 filed
  • 29300-0411-05 · Unichem Pharmaceuticals (USA), Inc. · $0.0236 per EA · eff. 2026-09-23 filed
  • 29300-0411-10 · Unichem Pharmaceuticals (USA), Inc. · $0.0236 per EA · eff. 2026-09-23 filed
  • 51079-0684-01 · not listed as a package in the FDA directory · $0.0236 per EA · eff. 2026-09-23 filed
  • 51079-0684-20 · Mylan Institutional Inc. · $0.0236 per EA · eff. 2026-09-23 filed
  • 64980-0438-01 · Rising Pharma Holdings, Inc. · $0.0236 per EA · eff. 2026-09-23 filed
  • 64980-0438-10 · Rising Pharma Holdings, Inc. · $0.0236 per EA · eff. 2026-09-23 filed
  • 65862-0169-01 · Aurobindo Pharma Limited · $0.0236 per EA · eff. 2026-09-23 filed
  • 65862-0169-99 · Aurobindo Pharma Limited · $0.0236 per EA · eff. 2026-09-23 filed
  • 68382-0023-01 · Zydus Pharmaceuticals USA Inc. · $0.0236 per EA · eff. 2026-09-23 filed
  • 68382-0023-10 · Zydus Pharmaceuticals USA Inc. · $0.0236 per EA · eff. 2026-09-23 filed
  • 75834-0282-00 · not listed as a package in the FDA directory · $0.0236 per EA · eff. 2026-09-23 filed
  • 83980-0023-01 · Ipca Laboratories Limited · $0.0236 per EA · eff. 2026-09-30 filed

Other strengths, forms and brands

3 other products in the NADAC file share the FDA nonproprietary name atenolol with ATENOLOL 50 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
ATENOLOL 25 MG TABLET
generic · tablet
$0.02171 per EA filed
eff. 2026-09-23 to 2026-09-30
$0.08799 per EA filed
Part D 2024 average
ATENOLOL 50 MG TABLET this page
generic · tablet
$0.0236 per EA filed
eff. 2026-09-23 to 2026-09-30
$0.08799 per EA filed
Part D 2024 average
ATENOLOL 100 MG TABLET
generic · tablet
$0.03614 per EA filed
eff. 2026-09-23
$0.08799 per EA filed
Part D 2024 average
TENORMIN 50 MG TABLET
brand · tablet
$12.7821 per EA filed
eff. 2026-09-23
$12.56706 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 17 NDCs’ NADAC prices is $0.0236 per EA filed.

Of the 76 other products in FDA’s beta-Adrenergic Blocker class priced per EA, 70 have a higher middle NADAC price and 6 a lower one. The one in the middle is NADOLOL 40 MG TABLET, at $0.26544 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $2.64 for 30 tablets, at an average of $0.08799 per EA in 2024 (2024-01-01 to 2024-12-31) for “Atenolol”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 6,459,376 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for ATENOLOL 50 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Atenolol / Atenolol: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.